Securities fraud litigation history and active cases
In Litigation
1
Settlement
0
Closed
1
Total Settlement
$3M
8:22cv1298 • June 6, 2022
Class Period Start
May 12, 2021
Class Period End
March 11, 2022
PSLRA Deadline
August 5, 2022
Case Allegations
10b5
Statutes of Repose
May 12, 2024
Country
United States
Court
Federal Court
Jun 15, 2023
Motion to Dismiss Denied in Part
The court has determined that plaintiffs have adequately alleged some of their claims, but have failed to adequately allege other claims. The judge has therefore denied in part the motion to dismiss filed by defendants and written an order stating which claims are dismissed and which remain. The case will proceed and parties will litigate the remaining claims.
Feb 13, 2023
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Dec 13, 2022
A new complaint has been filed on behalf of certain investors in Apyx Medical Corp. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
8:19cv919 • April 17, 2019
Class Period Start
December 21, 2018
Class Period End
June 28, 2019
PSLRA Deadline
June 17, 2019
Case Allegations
10b5
Statutes of Repose
Dec 21, 2021
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
December 16, 2020
Settlement Fund
$3,000,000
Settlement Status
Disbursed
Settlement Class
All persons or entities that purchased or otherwise acquired Apyx Medical Corporation common stock (“Apyx Common Stock”) or call options on Apyx Common Stock (“Apyx Call Options”), or sold put options on Apyx Common Stock (“Apyx Put Options”) during the period between December 21, 2018 and April 1, 2019, inclusive.
Claim Administrator
Strategic Claims Services
Pritchard v. Apyx Medical Corp., et al.
c/o Strategic Claims Services
P.O. Box 230
600 N. Jackson St., Suite 205 Media, PA 19063
+1 866-274-4004
[email protected]
Settlement Website
-Hearing Date
November 6, 2020
Opt-out Deadline
October 16, 2020
Settlement Note
Download hereProof Of Claim
Download hereJun 15, 2021
Disbursement Approved
The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.
Nov 6, 2020
Final Approval of Settlement
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Jul 21, 2020
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
Jul 21, 2020
Proof of Claim Form
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
TOP